220 related articles for article (PubMed ID: 32013101)
21. Lymphomatoid papulosis: an update and review.
Martinez-Cabriales SA; Walsh S; Sade S; Shear NH
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):59-73. PubMed ID: 31494989
[TBL] [Abstract][Full Text] [Related]
22. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW
Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
[TBL] [Abstract][Full Text] [Related]
23. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
[TBL] [Abstract][Full Text] [Related]
24. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
[TBL] [Abstract][Full Text] [Related]
26. Long-term Follow-up of a Case of Lymphomatoid Papulosis with a Benign Course.
Balić A; Bartolić L; Ilić I; Radoš J
Acta Dermatovenerol Croat; 2018 Oct; 26(3):264-266. PubMed ID: 30390731
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous anaplastic large-cell lymphoma of the eyelid: report of two cases and review of the literature.
Iuliano A; Fossataro F; Laezza MP; Lanni V; Mascolo M; Varricchio S; Uccello G; Tranfa F; Strianese D
Orbit; 2021 Dec; 40(6):481-487. PubMed ID: 32998605
[TBL] [Abstract][Full Text] [Related]
28. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
[TBL] [Abstract][Full Text] [Related]
29. [Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy].
Sumitani R; Harada T; Nakamura M; Mizuguchi M; Oura M; Sogabe K; Maruhashi T; Takahashi M; Fujii S; Nakamura S; Miki H; Kagawa K; Yada M; Matsudate Y; Uehara H; Abe M
Rinsho Ketsueki; 2022; 63(6):536-543. PubMed ID: 35831185
[TBL] [Abstract][Full Text] [Related]
30. Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients.
Wieser I; Oh CW; Talpur R; Duvic M
J Am Acad Dermatol; 2016 Jan; 74(1):59-67. PubMed ID: 26518172
[TBL] [Abstract][Full Text] [Related]
31. [Primary cutaneous lymphoma-a case series of 163 patients].
Nashan D; Friedrich CM; Geissler E; Schmitt-Graeff A; Klein F; Meiss F
Hautarzt; 2018 Dec; 69(12):1014-1020. PubMed ID: 29881891
[TBL] [Abstract][Full Text] [Related]
32. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin.
Drews R; Samel A; Kadin ME
Semin Cutan Med Surg; 2000 Jun; 19(2):109-17. PubMed ID: 10892712
[TBL] [Abstract][Full Text] [Related]
33. [Primary cutaneous anaplastic CD30+ large cell lymphoma].
Marrero-Calvo MD; Rodríguez-Serna M; Castejón-Calvete P; Peláez-Malagón S
Actas Dermosifiliogr; 2007 Apr; 98(3):194-7. PubMed ID: 17504705
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous CD30+ anaplastic large cell lymphoma: report of a rare case.
Chao-Lo MP; King-Ismael D; Lopez RA
J Dermatol Case Rep; 2008 Oct; 2(3):31-4. PubMed ID: 21886709
[TBL] [Abstract][Full Text] [Related]
35. ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
Geller S; Canavan TN; Pulitzer M; Moskowitz AJ; Myskowski PL
Int J Dermatol; 2018 May; 57(5):515-520. PubMed ID: 29057463
[TBL] [Abstract][Full Text] [Related]
36. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.
Tomaszewski MM; Lupton GP; Krishnan J; May DL
J Cutan Pathol; 1995 Aug; 22(4):310-8. PubMed ID: 7499570
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
38. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
[TBL] [Abstract][Full Text] [Related]
39. Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients.
Kunishige JH; McDonald H; Alvarez G; Johnson M; Prieto V; Duvic M
Clin Exp Dermatol; 2009 Jul; 34(5):576-81. PubMed ID: 19196298
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy.
Querfeld C; Kuzel TM; Guitart J; Rosen ST
Oncology (Williston Park); 2007 May; 21(6):689-96; discussion 699-700,. PubMed ID: 17564326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]